Careers  |  Sign In  |  Register

Latest in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Bendamustine more effective than chlorambucil for CLL

NEW YORK (Reuters Health) - As first-line therapy for advanced chronic lymphocytic leukemia, bendamustine produced significantly higher response rates and longer progression-free survival than chlorambucil in a phase III clinical trial. Bendamustine also evoked a “manageable toxicity profile,” Dr....

Reuters Health • The Doctor's Channel Daily Newscast

Less frequent INR testing suitable for some patients on anticoagulation

NEW YORK (Reuters Health) – INR testing intervals of 4 weeks or less are typically recommended for patients on long-term warfarin therapy, but new research suggests that less frequent testing may be safe for patients with stable INR values. “Although multiple studies have addressed the optimum target...

Reuters Health • The Doctor's Channel Daily Newscast

Allogeneic transfusions may trigger systemic immunosuppression

NEW YORK (Reuters Health) - Allogeneic blood transfusions in patients who undergo coronary artery bypass graft surgery (CABG) substantially increase the patient’s odds of nosocomial infection, hospital readmission within 30 days and mortality, the results of a recent cohort study propose. What’s more,...